UNDERSTANDING THE PSYCHONAUT PERSPECTIVE ON CATHINONES

N-Ethylhexedrone was patented through the German pharmaceutical organization Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[1]potential new hazards which will result in. Up to now, not simply health actors but additionally most people must be EvidentlyI